Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3872678

CN(C)Cc1ccc(CCN)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 6/20 0.44
LSS P48449 1/20 0.43
HTR5A P47898 3/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
MCHR1 Q99705 2/20 0.42
ALDH1A1 P00352 2/20 0.41
HRH3 Q9Y5N1 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4277824 0.82 HRH3 (0.58) TAAR1ALDH1A1HRH3TSHRCYP2C19
Trifluoroacetic Acid SCHEMBL27585620 0.81 ALDH1A1 (0.65) TAAR1HTR5AHDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL30182723 0.81 TAAR1 (0.52) TAAR1ALDH1A1TSHRCYP2C19CYP1A2
Hydrochloric Acid SCHEMBL1569888 0.80 HRH3 (0.56) TAAR1ALDH1A1HRH3TSHRCYP2C19
Hydrochloric Acid SCHEMBL3625400 0.80 HRH3 (0.56) TAAR1ALDH1A1HRH3TSHRCYP2C19
Tyramine SCHEMBL6433562 0.80 TAAR1 (0.67) TAAR1ALDH1A1TSHRCYP2C19CYP1A2
Trifluoroacetic Acid SCHEMBL7859231 0.80 TAAR1 (0.67) TAAR1ALDH1A1TSHRCYP2C19CYP1A2
Phenethylamine SCHEMBL20239925 0.79 TAAR1 (0.64) TAAR1CYP2A6
Trifluoroacetic Acid SCHEMBL29484053 0.78 TAAR1 (0.64) TAAR1ALDH1A1TSHRCYP2C19CYP1A2
Trifluoroacetic Acid SCHEMBL29484054 0.78 TAAR1 (0.64) TAAR1ALDH1A1TSHRCYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601868-B2 Such as 4-(cyclopropylmethoxy)-N-(2-{4-[1-(1-pyrrolidinyl)ethyl]phenyl}ethyl)benzamide having melanin-concentrating hormone antagonistic action, for prophylaxis and/or treatment of obesity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-13 US disclosed
US-20060128690-A1 Amine derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-15 US disclosed
EP-1593667-A1 AMINE DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2005-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128690-A1 Amine derivative MC1R, MC2R, MC4R TAAR1 42/4885LSS 2955/4885HTR5A 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.